肺移植活检中急性细胞性排斥与抗体介导排斥的诊断:肺病理学会成员视角
本文基于国际心肺移植学会(ISHLT)报告、肺病理学会(PPS)成员经验及PubMed文献检索,阐述肺移植经支气管活检的诊断路径。急性细胞性排斥应按2007年ISHLT工作分型评估和分级;抗体介导排斥(AMR)尚无特异组织学特征,建议联合临床、供者特异性抗体及病理发现的三联检测诊断,C4d染色可在提示AMR时进行。
要点
- 急性细胞性排斥按2007年ISHLT工作分型评估和分级。
- AMR无特异组织学特征,需联合临床、血清学与病理三联检测。
- 形态学、临床或血清学提示AMR时可进行C4d染色。
核心结论
- 急性细胞性排斥应按照2007年ISHLT工作分型进行评估和分级。
- 肺移植AMR目前无已知特异特征,应采用三联检测(临床移植物功能障碍、供者特异性抗体、病理发现)诊断。
- 当形态学、临床和/或血清学特征提示AMR时,可进行C4d染色。
研究设计与样本
- 基于ISHLT报告、PPS成员常规审核肺移植活检的经验及PubMed文献数据库检索的视角性总结。
主要发现
- 急性细胞性排斥在组织学上定义明确,而AMR目前未识别出可重复的特异特征。
- AMR诊断建议联合临床特征、血清学、组织病理学和免疫学发现。
关键数值与推荐
- 急性细胞性排斥按2007年ISHLT工作分型评估和分级。
- AMR诊断采用三联检测:临床移植物功能障碍、供者特异性抗体、病理发现。
- 形态学、临床和/或血清学提示AMR时可行C4d染色。
临床怎么用
- 肺移植活检评估急性细胞性排斥时遵循2007年ISHLT工作分型进行分级。
- 诊断AMR时联合临床移植物功能障碍、供者特异性抗体和病理发现进行综合判断。
- 在形态学、临床或血清学提示AMR时考虑进行C4d染色。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: - The diagnosis and grading of acute cellular and antibody-mediated rejection (AMR) in lung allograft biopsies is important because rejection can lead to acute graft dysfunction and/or failure and may contribute to chronic graft failure. While acute cellular rejection is well defined histologically, no reproducible specific features of AMR are currently identified. Therefore, a combination of clinical features, serology, histopathology, and immunologic findings is suggested for the diagnosis of AMR. OBJECTIVE: - To describe the perspective of members of the Pulmonary Pathology Society (PPS) on the workup of lung allograft transbronchial biopsy and the diagnosis of acute cellular rejection and AMR in lung transplant. DATA SOURCES: - Reports by the International Society for Heart and Lung Transplantation (ISHLT), experience of members of PPS who routinely review lung allograft biopsies, and search of literature database (PubMed). CONCLUSIONS: - Acute cellular rejection should be assessed and graded according to the 2007 working formulation of the ISHLT. As currently no specific features are known for AMR in lung allografts, the triple test (clinical allograft dysfunction, donor-specific antibodies, pathologic findings) should be used for its diagnosis. C4d staining might be performed when morphologic, clinical, and/or serologic features suggestive of AMR are identified.
引用
- Roden AC, Aisner DL, Allen TC, et al. Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med. 2016. PMID: 27819763. doi:10.5858/arpa.2016-0459-SA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。